ES554125A0 - Procedimiento de preparar hidroxamatos farmaceuticamente activos. - Google Patents

Procedimiento de preparar hidroxamatos farmaceuticamente activos.

Info

Publication number
ES554125A0
ES554125A0 ES554125A ES554125A ES554125A0 ES 554125 A0 ES554125 A0 ES 554125A0 ES 554125 A ES554125 A ES 554125A ES 554125 A ES554125 A ES 554125A ES 554125 A0 ES554125 A0 ES 554125A0
Authority
ES
Spain
Prior art keywords
hydroxamates
procedure
pharmaceutically active
preparing pharmaceutically
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES554125A
Other languages
English (en)
Other versions
ES8708127A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
USV Pharmaceutical Corp
Original Assignee
USV Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by USV Pharmaceutical Corp filed Critical USV Pharmaceutical Corp
Publication of ES8708127A1 publication Critical patent/ES8708127A1/es
Publication of ES554125A0 publication Critical patent/ES554125A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES554125A 1985-04-03 1986-04-03 Procedimiento de preparar hidroxamatos farmaceuticamente activos. Expired ES8708127A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71919985A 1985-04-03 1985-04-03
US06/830,798 US4792560A (en) 1985-04-03 1986-02-19 Quinoline hydroxamates and their use as modulators of arachidonic acid metabolic pathways

Publications (2)

Publication Number Publication Date
ES8708127A1 ES8708127A1 (es) 1987-10-16
ES554125A0 true ES554125A0 (es) 1987-10-16

Family

ID=27110043

Family Applications (1)

Application Number Title Priority Date Filing Date
ES554125A Expired ES8708127A1 (es) 1985-04-03 1986-04-03 Procedimiento de preparar hidroxamatos farmaceuticamente activos.

Country Status (7)

Country Link
US (1) US4792560A (es)
EP (1) EP0196674A3 (es)
AU (1) AU5568186A (es)
DK (1) DK150986A (es)
ES (1) ES8708127A1 (es)
FI (1) FI861444A7 (es)
NO (1) NO861306L (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4607053A (en) * 1984-05-17 1986-08-19 E. R. Squibb & Sons, Inc. Arylhydroxamates useful as antiallergy agents
IE59397B1 (en) * 1985-03-16 1994-02-23 Wellcome Found New aryl derivatives
GB8531839D0 (en) * 1985-12-30 1986-02-05 Wellcome Found Aryl derivatives
US4861798A (en) * 1986-12-29 1989-08-29 Bristol-Myers Company Lipoxygenase inhibitory compounds
US4731382A (en) * 1986-12-29 1988-03-15 Bristol-Myers Company Lipoxygenase inhibitory phenylalkanohydroxamic acids
US5155110A (en) * 1987-10-27 1992-10-13 Warner-Lambert Company Fenamic acid hydroxamate derivatives having cyclooxygenase and 5-lipoxygenase inhibition
US5112868A (en) * 1988-05-19 1992-05-12 Warner-Lambert Company Hydroxamate derivatives of selected nonsteroidal antiinflammatory acyl residues having cyclooxygenase and 5-lipoxygenase inhibition
US4943587A (en) * 1988-05-19 1990-07-24 Warner-Lambert Company Hydroxamate derivatives of selected nonsteroidal antiinflammatory acyl residues and their use for cyclooxygenase and 5-lipoxygenase inhibition
IL92915A0 (en) * 1989-01-05 1990-09-17 Ciba Geigy Ag Certain pyrrolylphenyl-substituted hydroxamic acid derivatives
US5096919A (en) * 1989-01-05 1992-03-17 Ciba-Geigy Corporation Pyrrolylphenyl-substituted hydroxamic acid derivatives
US4960787A (en) * 1989-02-06 1990-10-02 Ciba-Geigy Corporation Certain pyrrolyl-substituted hydroxamic acid derivatives
US5112846A (en) * 1989-05-26 1992-05-12 Warner-Lambert Company N-hydroxyamide, N-hydroxythioamide, hydroxyurea, and N-hydroxythiourea derivatives of selected nsaids as antiinflammatory agents
US5075330A (en) * 1989-05-26 1991-12-24 Warner-Lambert Co. N-hydroxyamide, N-hydroxythioamide, N-hydroxyurea, and N-hydroxythiourea derivatives of selected NSAIDS as antiinflammatory agents
US4981865A (en) * 1989-05-26 1991-01-01 Warner-Lambert Co. N-hydroxyamide, N-hydroxythioamide, hydroxyurea, and N-hydroxythiourea derivatives of selected nsaids as antiinflammatory agents
US5155130A (en) * 1989-08-11 1992-10-13 Ciba-Geigy Corporation Certain benzopyran and benzothiopyran derivatives
US5229516A (en) * 1989-10-27 1993-07-20 American Home Products Corporation Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole-alkanoic acid derivatives as inhibitors of PLA2 and lipoxygenase
US5017604A (en) * 1990-04-11 1991-05-21 Warner-Lambert Company Novel fenamic acid methyl hydroxamate derivatives having cyclooxygenase and 5-lipoxygenase inhibition
US5120758A (en) * 1991-02-08 1992-06-09 Ciba-Geigy Corporation Certain benzodioxole, benzodioxane and benzodioxepin derivatives useful as 5-lipoxygenase inhibitors
US5140047A (en) * 1991-05-03 1992-08-18 Smithkline Beecham Corporation Lipoxygenase inhibitors
US5334600A (en) * 1991-07-30 1994-08-02 Ciba-Geigy Corporation Isoquinolyl substituted hydroxylamine derivatives
US5350761A (en) * 1991-07-30 1994-09-27 Ciba-Geigy Corporation Indolyl substituted hydroxylamine derivatives
US5260316A (en) * 1991-07-30 1993-11-09 Ciba-Geigy Corporation Isoquinolyl substituted hydroxylamine derivatives
US5358955A (en) * 1992-10-30 1994-10-25 Abbott Laboratories Aryl and heteroarylmethoxyphenyl inhibitors of leukotriene biosynthesis
IT1283637B1 (it) * 1996-05-14 1998-04-23 Italfarmaco Spa Composti ad attivita' antinfiammatoria ed immunosoppressiva
EP1233958B1 (en) 1999-11-23 2011-06-29 MethylGene Inc. Inhibitors of histone deacetylase
EP1383729A4 (en) * 2001-04-05 2006-04-19 Smithkline Beecham Corp DEFORMYLASE PEPTIDE INHIBITORS
US8796330B2 (en) * 2006-12-19 2014-08-05 Methylgene Inc. Inhibitors of histone deacetylase and prodrugs thereof
GB0821010D0 (en) 2008-11-17 2008-12-24 Univ Warwick Plant development control composition
WO2013006444A1 (en) * 2011-07-01 2013-01-10 The George Washington University Compounds for inhibiting 1- deoxy-d-xylulose- 5 - phosphate reductoisomerase
US9636298B2 (en) 2014-01-17 2017-05-02 Methylgene Inc. Prodrugs of compounds that enhance antifungal activity and compositions of said prodrugs

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6406688A (es) * 1964-06-05 1965-12-06
BE689347A (es) * 1965-12-09 1967-04-14 Madan Ag
US3481970A (en) * 1967-05-08 1969-12-02 Standard Oil Co Process for preparation of beta-chloromethacrylonitrile
SE363818B (es) * 1968-08-15 1974-02-04 Lilly Co Eli
GB1396726A (en) * 1972-06-15 1975-06-04 Boots Co Ltd Phenylalkanoic acids
IT1046338B (it) * 1974-12-06 1980-06-30 Manetti & Roberts Italo Brit Procedimento per preparare aoido 2,4 isoputil fenil propioidros sanico e combusto intermerio beriesso
NL7614113A (nl) * 1976-12-18 1978-06-20 Akzo Nv Hydroxamzuren.

Also Published As

Publication number Publication date
ES8708127A1 (es) 1987-10-16
DK150986D0 (da) 1986-04-03
FI861444A0 (fi) 1986-04-03
FI861444A7 (fi) 1986-10-04
EP0196674A3 (en) 1988-06-15
AU5568186A (en) 1986-10-09
DK150986A (da) 1986-10-04
EP0196674A2 (en) 1986-10-08
US4792560A (en) 1988-12-20
NO861306L (no) 1986-10-06

Similar Documents

Publication Publication Date Title
ES554125A0 (es) Procedimiento de preparar hidroxamatos farmaceuticamente activos.
DK175487A (da) Farmaceutisk aktive 2-thiomethyl-substitueret-1,4-dihydro-pyridiner
AU1709888A (en) Pharmaceutically active amines
FI870903L (fi) Menetelmä terapeuttisesti aktiivisten alfa-heterosykleillä substituoitujen tolunitriilien valmistamiseksi
FI865109L (fi) Brukssystem foer aktivaemnen.
DK268786D0 (da) Aktive forbindelser
DK394586A (da) Fungicidt aktive propenoatderivater
DK224687D0 (da) Aktive forbindelser
KR960004771B1 (en) Pharmacologically active catechol derivatives
PT86000A (en) Pharmaceutically active compounds
NO864674D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser.
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
IT8820550A0 (it) Benzammidi sostituite farmacologicamente attive.
FI88825C (fi) Aktivt pansar
FI861006A7 (fi) Menetelmä farmaseuttisesti aktiivisten eetterien valmistamiseksi.
NO870533D0 (no) Terapeutisk aktive 3-alkoksy-2-aminopropylaminer.
TR24383A (tr) Konsantre yuezey aktif madde granuelleri yapmaya mahsus yoentem
IT8521235A0 (it) Composti farmacologicamente attivi.
FI880103L (fi) Menetelmä terapeuttisesti aktiivisen sialosyylikolesterolin valmistamiseksi
FI853343A7 (fi) Menetelmä farmaseuttisesti aktiivisten fenyyli-asetonitriilijohdannaisten valmistamiseksi.
FI883254A0 (fi) Cytostatiskt aktiva antracyklinderivat.
NO164973C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive gem-dihalo- og tetrahalo-1,2-diamino-4,9,-diaza-dodecaner.
DK303886D0 (da) Aktive forbindelser
DK674187D0 (da) Aktive forbindelser
DE68908838D1 (de) Pharmazeutisch wirksame Dithioketen-Derivaten.